Fagron NV operates globally, with a presence in over 30 countries across Europe, the Americas, and the Asia-Pacific region. The company's business is structured into three main segments: Essentials, Brands, and Compounding Services. The Essentials segment distributes pharmaceutical-grade raw materials and active pharmaceutical ingredients (APIs) to healthcare providers. The Brands segment develops innovative vehicles, semi-finished products, and specialized compounding equipment. The Compounding Services segment provides ready-to-administer and ready-to-dispense customized medications, including both sterile and non-sterile formulations, directly to medical institutions. By focusing on the niche market of personalized medicine, Fagron supports healthcare professionals in delivering bespoke treatments while navigating complex regulatory environments.
